1887

Chapter 134 : and

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

and , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap134-1.gif /docserver/preview/fulltext/10.1128/9781555816728/9781555814632_Chap134-2.gif

Abstract:

spp. and spp. are protozoa belonging to the family . Recent estimates suggest that there are approximately 350 million people at risk of acquiring leishmaniasis, with 112 million currently infected. All adult female sand flies transmitting leishmaniasis belong to the genus in the Old World and in the New World. There are more than 30 species of sand flies that can transmit leishmaniasis. Mucocutaneous leishmaniasis is produced most often by the complex. The majority of infected individuals are asymptomatic or have very few or minor symptoms that resolve without therapy. PCR-based methods for the diagnosis of leishmaniasis have used a variety of specimens, including urine. Molecular techniques for the detection of leishmanial DNA or RNA have been used for diagnosis, prognosis, and species identification. These methods are considered more sensitive than slide examination or culture, particularly for the detection of mucocutaneous leishmaniasis. Promastigote stages can be detected microscopically in wet mounts and then stained with Giemsa stain to observe their morphology. Positive reactions are usually seen in cutaneous and mucocutaneous leishmaniasis; however, patients with active visceral and diffuse cutaneous leishmaniasis exhibit negative reactions. American trypanosomiasis (Chagas' disease) is a zoonosis caused by . Population-screening programs have been used to control infections. The most effective control measures include an integrated approach to reduce the human reservoir of infection and the use of insecticide and fly traps.

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134

Key Concept Ranking

Chagas' Disease
0.55959386
Highly Active Antiretroviral Therapy
0.41102332
0.55959386
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Life cycle stages of spp.

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

(A) amastigotes from splenic press preparation (Giemsa stain); (B) amastigotes in liver (hematoxylin and eosin stain).

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

promastigotes (Giemsa stain).

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Life cycle stages of trypanosomes.

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5
FIGURE 5

(A and B) trypomastigotes; (C and D) trypomastigotes.

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 6
FIGURE 6

epimastigotes (Giemsa stain).

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 7
FIGURE 7

amastigotes in heart muscle (hematoxylin and eosin stain).

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816728.chap134
1. Almeida, I. C.,, D. T. Covas,, L. M. Soussumi,, and L. R. Travassos. 1997. A highly sensitive and specific chemiluminescent enzyme-linked immunosorbent assay for diagnosis of active Trypanosoma cruzi infection. Transfusion 37:850857.
2. Anthony, R. L.,, T. S. Cody,, and N. T. Constantin. 1981. Antigenic differentiation of Trypanosoma C7-2i and Trypanosoma rangeli by means of monoclonal-hybridoma antibodies. Am. J. Trop. Med. Hyg. 30:11911197.
3. Antinori, S.,, A. Cascio,, C. Parravicini,, R. Bianchi,, and M. Corbellino. 2008. Leishmaniasis among organ transplant recipients. Lancet Infect. Dis. 8:191199.
4. Antinori, S.,, E. Gianelli,, S. Calatini,, E. Longhi,, M. Gramiccia,, and M. Corbellino. 2004. Cutaneous leishmaniasis: an increasing threat for travelers. Clin. Microbiol. Infect. 11:343346.
5. Aparicio, I. M.,, J. Scharfstein,, and A. P. C. A. Lima. 2004. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infect. Immun. 72:58925902.
6. Arora, S. K.,, S. Gupta,, S. Bhardwaj,, N. Sachdeva,, and N. L. Sharma. 2008. An epitope-specific PCR test for diagnosis of Leishmania donovani infections. Trans. R. Soc. Trop. Med. Hyg. 102:4145.
7. Attar, Z. J.,, M. L. Chance,, S. el-Safi,, J. Carney,, A. Azazy,, M. El-Hadi,, C. Dourado,, and M. Hommel. 2001. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop. 78:1116.
8. Balmer, O.,, and A. Caccone. 2008. Multiple-strain infections of Trypanosoma brucei across Africa. Acta Trop. 107: 275279.
9. Barnabe, C.,, R. Yaegar,, O. Pung,, and M. Tibayrenc. 2001. Trypanosoma cruzi: a considerable phylogenic divergence indicates that the agent of Chagas disease is indigenous to the native fauna of the United States. Exp. Parasitol. 99:7379.
10. Barrett, M. P.,, R. J. S. Burchmore,, A. Stich,, J. O. Lazzari,, A. C. Frasch,, J. J. Cazzulo,, and S. Krishna. 2003. The trypanosomiasis. Lancet 362:14691480.
11. Barrett, S. V.,, and M. P. Barrett. 2000. Anti-sleeping sickness drugs and cancer chemotherapy. Parasitol. Today 16:79.
12. Becker, S.,, J. R. Franco,, P. P. Simarro,, A. Stich,, P. M. Abel,, and D. Steverding. 2004. Real-time PCR for detection of Trypanosoma brucei in human blood samples. Diagn. Microbiol. Infect. Dis. 50:193199.
13. Bern, C.,, S. Jha,, A. B. Joshi,, G. D. Thakur,, and M. B. Bista. 2000. Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal. Am. J. Trop. Med. Hyg. 63:153157.
14. Blum, J. A.,, M. J. Zellweger,, C. Burri,, and C. Hatz. 2008. Cardiac involvement in African and American trypanosomiasis. Lancet Infect. Dis. 8:631641.
15. Boarino, A.,, A. Scalone,, L. Gradoni,, E. Ferroglio,, E. Vitale,, R. Zanatta,, M. G. Giuffrida,, and S. Rosati. 2005. Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin. Diagn. Lab. Immunol. 12:647653.
16. Braz, R. E. S.,, E. T. Nascimento,, D. R. A. Martins,, M. E. Wilson,, R. D. Pearson,, S. G. Reed,, and S. M. B. Jeronimo. 2002. The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection. Am. J. Trop. Med. Hyg. 67:344348.
17. Brito, M. E. F.,, M. G. Mendonca,, Y. M. Gomes,, M. L. Jardim,, and F. G. C. Abath. 2000. Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis. Clin. Diagn. Lab. Immunol. 7:318321.
18. Britto, C.,, M. A. Cardoso,, C. M. M. Vanni,, A. Hasslocher- Moreno,, S. S. Xavier,, W. Oelemann,, A. Santoro,, C. Pirmez,, C. M. Morel,, and P. Wincker. 1995. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as tool for diagnosis and treatment evaluation. Parasitology 110:241247.
19. Buchovsky, A. S.,, O. Campetella,, G. Russomando,, L. Franco,, R. Oddone,, N. Candia,, A. Luquetti,, S. M. G. Cappa,, and M. S. Leguizamon. 2001. trans-Sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas’ disease. Clin. Diagn. Lab. Immunol. 8:187189.
20. Campos, R. F.,, M. L. S. Guerreiro,, K. D. S. C. Sobral,, R. D. C. P. C. Lima,, and S. G. Andrade. 2005. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme type II, Trypanosoma cruzi II). Rev. Soc. Bras. Med. Trop. 38:142146.
21. Castro, E. 2009. Chagas’ disease: lessons from routine donation testing. Transfusion Med. 19:1623.
22. Cattand, P.,, B. T. Miezan,, and P. de Rasdt. 1988. Human African trypanosomiasis: use of double centrifugation of cerebrospinal fluid to detect trypanosomes. Bull. W. H. O. 66:8386.
23.Centers for Disease Control. 1992. Viscerotropic leishmaniasis in persons returning from Operation Desert Storm 1990-1991. MMWR Morb. Mortal. Wkly. Rep. 41:131134.
24.Centers for Disease Control and Prevention. 2003. Cutaneous leishmaniasis in U.S. military personnel—Southwest/ Central Asia, 2002-2003. MMWR Morb. Mortal. Wkly. Rep. 52:10091012.
25.Centers for Disease Control and Prevention. 2007. Blood donor screening for Chagas’ disease—United States, 2006- 2007. MMWR Morb. Mortal. Wkly. Rep. 56:141143.
26. Chappuis, F.,, L. Loutan,, P. Simarro,, V. Lejon,, and P. Buscher. 2005. Options for field diagnosis of human African trypanosomiasis. Clin. Microbiol. Rev. 18:133146.
27. Chiaramonte, M. G.,, F. M. Frank,, G. M. Furer,, N. J. Taranto,, R. A. Margni,, and E. L. Malchiodi. 1999. Polymerase chain reaction reveals Trypanosoma cruzi infection suspected by serology in cutaneous and mucocutaneous leishmaniasis patients. Acta Trop. 72:295308.
28. Chiurillo, M. A.,, G. Crisante,, A. Rojas,, A. Peralta,, M. Dias,, P. Guevara,, N. Anez,, and J. L. Ramirez. 2003. Detection of Trypanosoma cruzi and Trypanosoma rangeli infection by duplex PCR assay based on telomeric sequences. Clin. Diagn. Lab. Immunol. 10:775779.
29. Cordeiro, F. D.,, O. A. Martins-Filho,, M. O. C. Rocha,, S. J. Adad,, R. Correa-Oliveira,, and A. J. Romanha. 2001. Anti- Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas’ disease. Clin. Diagn. Lab. Immunol. 8:112118.
30. Coura, J. R. 2007. Chagas’ disease: what is known and what is needed-a background article. Mem. Inst. Oswaldo Cruz 102: 113122.
31. Cupolillo, E.,, E. Medina-Acosta,, H. Noyes,, H. Momen,, and G. Grimaldi, Jr. 2000. A revised classification for Leishmania and Endotrypanum. Parasitol. Today 16:142144.
32. Da-Cruz, A. M.,, R. P. Igreja,, W. Dantas,, A. C. V. Junqueira,, R. S. Pacheco,, A. J. Silva-Goncalves,, and C. Pirmez. 2004. Long-term follow-up of co-infected HIV and Trypanosoma cruzi Brazilian patients. Trans. R. Soc. Trop. Med. Hyg. 98:728733.
33. Da Silva, F. M.,, H. Noyes,, M. Campaner,, A. C. V. Junqueira,, J. R. Coura,, N. Anez,, J. J. Shaw,, J. R. Stevens,, and M. M. G. Teixeira. 2004. Phylogeny, taxonomy and grouping of Trypanosoma rangeli isolates from man, triatomines and sylvatic mammals from widespread geographical origin based on SSU and ITS ribosomal sequences. Parasitology 129:549561.
34. Da Silva, F. M.,, A. C. Rodrigues,, M. Campaner,, C. S. A. Takata,, M. C. Brigido,, A. C. V. Junqueira,, J. R. Coura,, G. F Takeda,, J. J. Shaw,, and M. M. G. Teixeira. 2004. Randomly amplified polymorphic DNA analysis of Trypanosoma rangeli and allied species from human, monkeys and other sylvatic mammals of the Brazilian Amazon disclosed a new group and a species-specific market. Parasitology 128:283294.
35. Da Silveira, J. L.,, E. S. Umezawa,, and A. O. Luquetti. 2001. Chagas’ disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol. 17:286291.
36. D’Avila, D. A.,, A. M. Macedo,, H. M. S. Valadares,, E. D. Gontijo,, A. M. de Castro,, C. R. Machado,, E. Chiari,, and L. M. C. Galvao. 2009. Probing population dynamics of Trypanosoma cruzi during progression of the chronic phase in chagasic patients. J. Clin. Microbiol. 47:17181725.
37. Di Pentima, M. C.,, and M. S. Edwards. 1999. Enzyme linked immunosorbent assay for IgA antibodies to Trypanosoma cruzi in congenital infections. Am. J. Trop. Med. Hyg. 60:211214.
38. Disch, J.,, M. J. Pedras,, M. Orsini,, C. Pirmez,, M. C. de Oliveria,, M. Castro,, and A. Rabello. 2005. Leishmania (Viannia) subgenus kDNA amplification for the diagnosis of mucosal leishmaniasis. Diagn. Microbiol. Infect. Dis. 51:185190.
39. Dubois, M. E.,, K. P. Demick,, and J. M. Mansfield. 2005. Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system. Infect. Immun. 73:26902697.
40. Duffy, T.,, M. Bisio,, J. Altcheh,, J. M. Burgos,, M. Diez,, M. J. Levin,, R. R. Favaloro,, H. Freiilij,, A. B. Schijman. 2009. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients. PLoS Negl. Trop. Dis. 3:e419.
41. Faber, W. R.,, L. Oskam,, T. van Gool,, N. C. M. Kroon,, K. J. Knegt-Junk,, H. Hofwegen,, A. C. van der Wal,, and P. A. Kager. 2003. Value of diagnostic techniques for cutaneous leishmaniasis. J. Am. Acad. Dermatol. 49:7074.
42. Freitas, J. M.,, E. Lages-Silva,, E. Crema,, S. D. J. Pena,, and M. M. Macedo. 2005. Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues. Int. J. Parasitol. 35:411417.
43. Gangneux, J.,, J. Menotti,, E. Lorenzo,, C. Sarfati,, H. Blanche,, H. Bui,, E. Pratlong,, Y. Garin,, and F. Derouin. 2003. Prospective value of PCR amplification and sequencing for diagnosis and typing of Old World Leishmania infections in an area of nonendemicity. J. Clin. Microbiol. 41:14191422.
44. Garcia, A.,, V. Jamonneau,, E. Magnus,, C. Laveissere,, V. Lejon,, P. N’Guessan,, L. N’Dri,, N. van Meirvenne,, and P. Buscher. 2000. Follow-up of card agglutination trypanosomiasis test (CATT) positive but apparently aparasitaemic individuals in Cote d’Ivoire: evidence for a complex and heterogeneous population. Trop. Med. Int. Health 5:786793.
45. Garcia, A. L.,, A. Kindt,, K. W. Quispe-Tintaya,, H. Bermudez,, A. Llanos,, J. Arevalo,, A. L. Banuls,, S. De Doncker,, D. Le Ray,, and J. C. Dujardin. 2005. American tegumentary leishmaniasis: antigen-gene polymorphism, taxonomy and clinical pleomorphism. Infect. Genet. Evol. 5:109116.
46. Garcia, L. S. 2007. Diagnostic Medical Parasitology, 5th ed. ASM Press, Washington, DC.
47. Gomes, A. H. S.,, I. M. Armelin,, S. Z. Menon,, and V. L. Pereira-Chioccola. 2008. Leishmania (V.) braziliensis: detection by PCR in biopsies from patients with cutaneous leishmaniasis. Exp. Parasitol. 119:319324.
48. Guhl, F.,, and G. A. Vallejo. 2003. Trypanosoma ( Herpetosoma) rangeli Tejera, 1920-an updated review. Mem. Inst. Oswaldo Cruz 98:435442.
49. Haouas, N.,, N. Chargui,, E. Chaker,, M. Ben Said,, H. Babba,, S. Belhadj,, K. Kallel,, E. Pratlong,, J. P. Dedet,, H. Mezhoud,, and R. Azaiez. 2005. Anthroponotic cutaneous leishmaniasis in Tunisia: presence of Leishmania killicki outside its original focus of Tataouine. Trans. R. Soc. Trop. Med. Hyg. 99:499501.
50. Harms, G.,, and H. Feldmeier. 2005. The impact of HIV infection on tropical diseases. Infect. Dis. Clin. N. Am. 19: 121135.
51. Ismail, A.,, A. Kharazrni,, H. Permin,, and A. M. EI Hassam. 1997. Detection and characterization of Leishmania in tissues of patients with post kala-azar dermal leishmaniasis using a specific monoclonal antibody. Trans. R. Soc. Trop. Med. Hyg. 91:283285.
52. Jamjoom, M. B.,, R. W. Ashford,, P. A. Bates,, M. L. Chance,, S. J. Kemp,, P. C. Watts,, and H. A. Noyes. 2004. Leishmania donovani is the only cause of visceral leishmaniasis in East Africa; previous descriptions of L. infantum and “L. archibaldi” from this region are a consequence of convergent evolution in the isoenzyme data. Parasitology 129:399409.
53. Jannin, J.,, and P. Cattand. 2004. Treatment and control of human African trypanosomiasis. Curr. Opin. Infect. Dis. 17:565570.
54. Karp, C. L.,, and P. G. Auwaerter. 2007. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin. Infect. Dis. 45:12081213.
55. Kaur, R.,, V. K. Gupta,, A. C. Dhariwai,, D. C. Jain,, and L. Shiv. 2007. A rare case of trypanosomiasis in a two month old infant in Mumbai. J. Commun. Dis. 39:7174.
56. Kun, H. A.,, A. Moore,, L. Mascola,, F. Steurer,, G. Lawrence,, B. Kubak,, S. Radhakrishna,, D. Leiby,, R. Herron,, T. Mone,, R. Hunter,, M. Kuehnert, et al. 2009. Transmission of Trypanosoma cruzi by heart transplantation. Clin. Infect. Dis. 48:15341540.
57. Kyambadde, J. W.,, J. C. K. Enyaru,, E. Matovu,, M. Odit,, and J. F. Carasco. 2000. Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. Bull. W. H. O. 78:119124.
58. Leiby, D. A.,, R. M. Herron, Jr.,, G. Garratty,, and B. L. Herwaldt. 2008. Trypanosoma cruzi parasitemia in U.S. blood donors with serologic evidence of infection. J. Infect. Dis. 198:609613.
59. Lejon, V.,, and P. Büscher. 2005. Cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up. Trop. Med. Int. Health 10:395403.
60. Lejon, V.,, I. Roger,, D. M. Ngoyi,, J. Menten,, J. Robays,, F. X. N’Siesi,, S. Bisser,, M. Boelaert,, and P. Buscher. 2008. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis. Clin. Infect. Dis. 47:1522.
61. Magill, A. J. 2005. Cutaneous leishmaniasis in the returning traveler. Infect. Dis. Clin. N. Am. 19:241266.
62. Mahdi, M.,, E. M. Elamim,, S. E. Melville,, A. M. Musa,, J. M. Blackwell,, M. M. Mukhtar,, A. M. Elhassan,, and M. E. Ibrahim. 2005. Sudanese mucosal leishmaniasis: isolation of a parasite within the Leishmania donovani complex that differs genotypically from L. donovani causing classical visceral leishmaniasis. Infect. Genet. Evol. 5:2933.
63. Maldonado, C.,, S. Albino,, L. Vettorazzi,, O. Salomone,, J. C. Zlocowski,, C. Abiega,, M. Amuchastegui,, R. Cordoba,, and T. Alvarellos. 2004. Using polymerase chain reaction in early diagnosis of re-activated Trypanosoma cruzi infection after heart transplantation. J. Heart Lung Transplant. 23:13451348.
64. Mauricio, I. L.,, J. R. Stothard,, and M. A. Miles. 2000. A strange case of Leishmania chagasi. Parasitol. Today 16:188189.
65. Mendonca, M. G.,, M. E. F. deBrito,, E. H. G. Rodrigues,, V. Bandeira,, M. L. Jardim,, and F. G. C. Abath. 2004. Persistence of Leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J. Infect. Dis. 189:10181023.
66. Milei, J.,, R. A. Guerri-Guttenberg,, D. A. Grana,, and R. Storino. 2009. Prognostic impact of Chagas disease in the United States. Am. Heart J. 157:2229.
67. Moore, A. C. 2005. Prospects for improving African trypanosomiasis chemotherapy. J. Infect. Dis. 191:17931795.
68. Motazedian, M.,, M. Fakhar,, M. H. Motazedian,, G. Hatam,, and F. Mikaeili. 2008. A urine-based polymerase chain reaction method for the diagnosis of visceral leishmaniasis in immunocompetent patients. Diagn. Microbiol. Infect. Dis. 60: 151154.
69. Murray, H. W. 2005. Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis. J. Immunol. 174:49164923.
70. Napier, L. 1922. A new serum test for kala-azar. Indian J. Med. Res. 9:830846.
71. Navrn, T. R.,, R. R. Roberto,, D. D. Juranek,, K. Limpakarnjanarat,, E. W. Mortenson,, J. R. Clover,, R. E. Yescott,, C. Taclindo,, F. Stuerer,, and D. Allain. 1985. Human and sylvatic Trypanosoma cruzi infection in California. Am. J. Public Health 75:366369.
72. Negrette, O. S.,, F. J. S. Valdez,, C. D. Lacunza,, M. F. G. Bustos,, M. C. Mora,, A. D. Uncos,, and M. A. Basombrio. 2008. Serological evaluation of specific-antibody levels in patients treated for chronic Chagas’ disease. Clin. Vaccine Immunol. 15:297302.
73. Oliveira, J. G. S.,, F. O. Novais,, C. I. de Oliveira,, A. C. da Cruz, Jr.,, L. F. Campos,, A. V. da Rocha,, V. Boaventura,, A. Noronha,, J. M. L. Costa,, and A. Barral. 2005. Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis. Acta Trop. 94:5559.
74. Oliveira, R. A.,, L. S. V. Silva,, V. P. Carvalho,, A. F. Coutinho,, F. G. Pinheiro,, C. G. Lima,, J. E. Leandro, Jr.,, G. B. Silva, Jr.,, and E. F. Daher. 2008. Visceral leishmaniasis after renal transplantation: report of 4 cases in Northeastern Brazil. Transpl. Infect. Dis. 10:364368.
75. Olivier, M.,, D. J. Gregory,, and G. Forget. 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18:293305.
76. Otani, M. M.,, E. Vinelli,, L. V. Kirchhoff,, A. del Pozo,, A. Sands,, G. Vercauteren,, and E. C. Sabino. 2009. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion 49:10761082.
77. Paiva, B. R.,, L. N. Passos,, A. Falqueto,, R. S. Malfronte,, and H. F. de Andrade, Jr. 2004. Single step polymerase chain reaction (PCR) for the diagnosis of the Leishmania (Viannia) subgenus. Rev. Inst. Med. Trop. Sao Paulo 46:335338.
78. Palumbo, E. 2008. Oral miltefosine treatment in children with visceral leishmaniasis: a brief review. Braz. J. Infect. Dis. 12:24.
79. Pereira, K. S.,, F. L. Schmidt,, A. M. Guaraldo,, R. M. Franco,, V. L. Dias,, and L. A. Passos. 2009. Chagas’ disease as a foodborne illness. J. Food Prot. 72:441446.
80. Pizzuto, M.,, M. Piazza,, D. Senese,, C. Scalamogna,, S. Calattini,, L. Corsico,, T. Persico,, B. Adriani,, C. Magni,, G. Guaraldi,, G. Gaiera,, A. Ludovisi,, M. Gramiccia,, M. Galli,, M. Moroni,, M. Corbellino,, and S. Antinori. 2001. Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J. Clin. Microbiol. 39:357361.
81. Reithinger, R.,, and J. Dujardin. 2007. Molecular diagnosis of leishmaniasis: current status and future applications. J. Clin. Microbiol. 45:2125.
82. Romero, G. A. S.,, M. V. F. Guerra,, M. G. Paes,, E. Cupolillo,, C. B. Toaldo,, V. O. Macedo,, and O. Fernandes. 2001. Sensitivity of the polymerase chain reaction for the diagnosis of cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis. Acta Trop. 79:225229.
83. Saez-Alquezar, A.,, E. C. Sabino,, N. Salles,, D. F. Chamone,, F. Hulstaert,, H. Pottel,, E. Stoops,, and M. Zrein. 2000. Serological confirmation of Chagas’ disease by a recombinant and peptide antigen line immunoassay: lNNO-LIA Chagas. J. Clin. Microbiol. 38:851854.
84. Saha, S.,, T. Mazumdar,, K. Anam,, R. Ravindran,, B. Bairagi,, B. Saba,, R. Goswami,, N. Pramanik,, S. K. Guha,, S. Kar,, D. Banerjee,, and N. Ali. 2005. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis. J. Clin. Microbiol. 43:12691277.
85. Salotra, P.,, G. Sreenivas,, G. P. Pogue,, N. Lee,, H. L. Nakhasi,, V. Ramesh,, and N. S. Negi. 2001. Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala- azar dermal leishmaniasis. J. Clin. Microbiol. 39:849854.
86. Sarataphan, N.,, M. Vongpakorn,, B. Nuansrichay,, N. Autarkool,, T. Keowkarnkah,, P. Rodtian,, R. W. Stich,, and S. Jittapalpong. 2007. Diagnosis of a Trypanosoma lewisi-like (Herpetosoma) infection in a sick infant from Thailand. J. Med. Microbiol. 56:11181121.
87. Schmid, C.,, M. Richer,, C. M. M. Bilenge,, T. Josenando,, F. Chappuis,, C. R. Manthelot,, A. Nangouma,, F. Doua,, P. N. Asumu,, P. P. Simarro,, and C. Burri. 2005. Effectiveness of a 10-day melarsoprol schedule for the treatment of latestage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). J. Infect. Dis. 191:19221931.
88. Schraner, C.,, B. Hasse,, U. Hasse,, D. Baumann,, A. Faeh,, G. Burg,, F. Grimm,, A. Mathis,, R. Weber,, and H. F. Gunthard. 2005. Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1. Clin. Infect. Dis. 40:120124.
89. Silveira, F. T.,, R. Lainson,, and C. E. P. Corbett. 2004. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Mem. Inst. Oswaldo Cruz 99:239251.
90. Simarro, P. P.,, J. A. Ruiz,, J. R. Franco,, and T. Josenando. 1999. Attitude towards CATT-positive individuals without parasitological confirmation in the African trypanosomiasis (T. b. gambiense) focus of Quicama (Angola). Trop. Med. Int. Health 4:858861.
91. Soto, J.,, J. Toledo,, J. Vega,, and J. Berman. 2005. Short report: efficacy of pentavalent antimony for treatment of Colombian cutaneous leishmaniasis. Am. J. Trop. Med. Hyg. 72:421422.
92. Sreenivas, G.,, B. V. S. Raju,, R. Singh,, A. Selvapandiyan,, R. Duncan,, D. Sarkar,, H. L. Nakhasi,, and P. Salotra. 2004. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause postkala- azar dermal leishmaniasis in humans. J. Clin. Microbiol. 42:17391741.
93. Strout, R. G. 1962. A method for concentrating haemoflagellates. J. Parasitol. 48:100.
94. Theis, J. H. 1990. Latin American immigrants-blood donation and Trypanosoma cruzi transmission. Am. Heart J. 120:14831484.
95. Toz, S. O.,, K. P. Chang,, Y. Ozbel,, and M. Z. Alkan. 2004. Diagnostic value of RK39 dipstick in zoonotic visceral leishmaniasis in Turkey. J. Parasitol. 90:14841486.
96. Trudel, N.,, R. Garg,, N. Messier,, S. Sundar,, M. Quellette,, and M. J. Tremblay. 2008. Intracellular survival of Leishmania spp. that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors. J. Infect. Dis. 198:12921298.
97. Unger, A.,, S. O’Neal,, P. R. L. Machado,, L. H. Guimaraes,, D. J. Morgan,, A. Schriefer,, O. Bacellar,, M. J. Glesby,, and E. M. Carvalho. 2009. Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in Northeastern Brazil. Am. J. Trop. Med Hyg. 80:574579.
98. van der Snoek, E. M.,, D. J. Robinson,, J. J. van Hellemond,, and H. A. M. Neumann. 2008. A review of photodynamic therapy in cutaneous leishmaniasis. J. Eur. Acad. Dermatol. Venereol. 22:918922.
99. Vergel, C.,, J. Walker,, and N. G. Saravia. 2005. Amplification of human DNA by primers targeted to Leishmania kinetoplast DNA and post-genome considerations in the detection of parasites by a polymerase chain reaction. Am. J. Trop. Med. Hyg. 72:423429.
100. Volpini, A. C.,, V. M. A. Passos,, G. C. Oliveira,, and A. J. Romanha. 2004. PCR-RFLP to identify Leishmania (Viannia) brasiliensis and L. (Leishmania) amazonensis causing American cutaneous leishmaniasis. Acta Trop. 90:3137.
101. Welch, R. J.,, B. L. Anderson,, and C. M. Litwin. 2008. Rapid immunochromatographic strip test for detection of anti-K39 immunoglobulin G antibodies for diagnosis of visceral leishmaniasis. Clin. Vaccine Immunol. 15:14831484.
102. Wilson, M. E.,, S. M. B. Jeronimo,, and R. D. Pearson. 2005. Immunopathogensis of infection with the visceralizing Leishmania species. Microb. Pathog. 38:147160.
103.World Health Organization. 2005. A new form of human trypanosomiasis in India. Wkly. Epidemiol. Rec. 80:6263.
104. Wright, N. A.,, L. E. Davis,, K. S. Aftergut,, C. A. Parrish,, and C. J. Cockerell. 2008. Cutaneous leishmaniasis in Texas: a northern spread of endemic areas. J. Am. Acad. Dermatol. 58:650652.
105. Zelazny, A. M.,, D. P. Fedorko,, L. Li,, E. A. Neva,, and S. H. Fischer. 2005. Evaluation of 7SL RNA gene sequences for the identification of Leishmania spp. Am. J. Trop. Med. Hyg. 72:415420.
106. Zulantay, I.,, W. Apt,, L. C. Gil,, C. Rocha,, K. Mundaca,, A. Solari,, G. Sanchez,, C. Rodriguez,, G. Martinez,, L. M. de Pablos,, L. Sandoval,, J. Rodriguez,, S. Vilchez,, and A. Osuna. 2007. The PCR-based detection of Trypanosoma cruzi in the faeces of Triatoma infestans fed on patients with chronic American trypanosomiasis gives higher sensitivity and a quicker result than routine xenodiagnosis. Ann. Trop. Med. Parasitol. 101:673679.

Tables

Generic image for table
TABLE 1

Features of human leishmanial infections

CL, cutaneous leishmaniasis; DCL, diffuse cutaneous leishmaniasis; DL, diffuse leishmaniasis; MCL, mucocutaneous leishmaniasis; VL, visceral leishmaniasis.

in the Old World 5 i in the New World.

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134
Generic image for table
TABLE 2

Characteristics of trypanosomiasis

Anthropozoonosis: transmission involving human-animal-human cycle.

Anthroponosis: transmission involving a human-human cycle.

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134
Generic image for table
TABLE 3

Diagnostic methods to detect Chagas' infections

EIA, enzyme immunoassay; IHA, indirect hemagglutinin assay; RIPA, radioimmunoprecipitation assay; WB, Western blot.

Citation: Bruckner D, Labarca J. 2011. and , p 2113-2126. In Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D (ed), Manual of Clinical Microbiology, 10th Edition. ASM Press, Washington, DC. doi: 10.1128/9781555816728.ch134

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error